drug development Related News
New treatment strategy to fight post-transplant infection
Scientists have discovered a potential treatment to protect immunocompromised patients from cytomegalovirus, a serious post-transplant infection.
‘New era’ for multiple sclerosis with £3.7m funding for research
The MS Society has awarded a grant of £3.7m to two UK ‘Centres of Excellence’ as part of its fight to stop multiple sclerosis...
Scientists track how Osmium reacts in single cancer cell
In a major step forward in discovering cancer treatments, scientists at the University of Warwick have tracked how the rare precious metal Osmium reacts in a single cancer cell.
New approach to creating Alzheimer’s drugs helps identify potential treatments
A team of scientists at the University of Sheffield have adopted a new method of creating Alzheimer’s drugs, which has identified two potential new treatments for the disease.
World’s first research and cultivation facility for psychedelic mushrooms
A new partnership will see the world’s first legal research and cultivation facility dedicated exclusively to psilocybin-producing mushrooms and other plant-based psychedelics.
Field Trip Health,...
The case for mass producing psychedelic pharmaceuticals
In this article, financial journalist Marc Davis discusses the mass production of psychedelic pharmaceuticals and the steep educational curve facing medical science.
Medical science is...
Oval Medical Technologies – Meeting the challenge of delivering high volume biologic therapies
The development of new biologic drugs and enabling a flexible autoinjector platform for the delivery of high viscosity or high-volume biologic formulations.
A novel treatment for cytokine storm
Tetra Bio-Pharma’s drug ARDS-003 has been cleared by the FDA for human trials to target sepsis and ARDS.
IT has been months in the making,...
New Oxford University institute to fight antimicrobial resistance
A £100m donation from Ineos will create a new state of the art institute for antimicrobial research.
The world leading Ineos Oxford Institute (IOI) will...
XPhyto: A leader in innovating psychedelic drugs
XPhyto Therapeutics Corp is exploring the role that psychedelic pharmaceutical drugs can play in combatting mental health conditions.
It’s a staggering statistic. A full 11%...
Reducing cardiovascular and cerebrovascular deaths with AstraZeneca
AstraZeneca’s recent THALES Phase III trial has demonstrated the efficacy of the drug Brilinta for reducing the risk of major cardiovascular events such as...
How data science is driving innovations in medical biotechnology
In this article, Ramya Sriram, digital content manager at freelance platform for scientists, Kolabtree, explains how data science is driving innovations in medical biotechnology.
It...
Artificial enzyme could lead to new Parkinson’s disease treatment
A team of researchers have created an artificial enzyme that could help form a new treatment for the neurodegenerative Parkinson’s disease.
The team from Johns...
Treating depression by ‘erasing’ neuroplasticity damage caused by stress
Researchers have used epigenetic modulators in an attempt at ‘erasing’ damage to neuroplasticity caused by stress, showing that acute intervention in epigenetic mechanisms produces...
Treating brain disorders with new nanoparticle drug delivery system
A new nanoparticle drug-delivery system could help scientists overcome the long-standing problem of delivering therapeutics across the blood-brain barrier and into the brain.
Progress has...
Long-acting injectable HIV treatment approved in Europe
The European Commission has approved marketing authorisation for the first long-acting injectable treatment for HIV to be made available in Europe.
REKAMBYS, a rilpivirine injection...
European Commission approves contract for potential COVID-19 vaccine
The European Commission has approved a contract with Moderna to secure access to a potential COVID-19 vaccine.
The contract will be the sixth one made...
COVID-19 vaccine Phase III clinical trials to begin in UK
Phase III clinical trials for a COVID-19 vaccine are set to begin in the UK and will involve 6,000 volunteers from across the country.
Global...
Potential lupus treatment reduces organ damaging corticosteroid use
The treatment anifrolumab has been found to reduce lupus flares whilst allowing for patients to reduce the use of corticosteroids that can cause organ...
World Health Organization addresses drug safety during COVID-19
The World Health Organization is highlighting the need for international drug safety monitoring during COVID-19.
For medicines to work safely, having strong systems in place...